National Academies Join Call For More Diversity In Trials
A new report from the National Academies of Sciences, Engineering, and Medicine issued a new report on the urgent need for better representation of underrepresented populations in clinical trials and research.
You may also be interested in...
Two of the most prominent features of the House package are not addressed in the Senate measure, which predominantly focuses on cosmetics, dietary supplements and laboratory developed tests. The absence of competing proposals suggests a smooth conference process.
Minute Insight: Abbott Sponsors New Physician Training Program To Diversity Clinical Trial Leadership
The company is partnering with the non-profit organization Women as One and the Global Cardiovascular Clinical Trialists to help train physicians from underrepresented populations to lead clinical trials.
Many companies have been signaling their commitment to diversity and inclusion in trials, but the new draft guidance spells out how they should address it and what the FDA wants to see.